22nd Century Group, Inc. (XXII) 股票分析

公司概述

22nd Century Group, Inc. operates within the consumer defensive sector as a specialized manufacturer and distributor of proprietary reduced nicotine tobacco products across the United States. The company focuses on the production and sale of very low nicotine combustible cigarettes alongside other reduced nicotine content tobacco offerings, effectively positioning itself in a niche segment of the broader tobacco industry. This enterprise employs a workforce of 32 individuals to manage its manufacturing and distribution operations, reflecting a highly lean organizational structure typical of small-cap entities. With a market capitalization of $1.54M and annual revenue of $7.05M, the company's valuation metrics suggest it operates as a micro-cap asset with limited scale relative to industry peers. These financial dimensions indicate that the firm possesses a minimal operational footprint, suggesting its market position is constrained to a specific, narrow geographic or product scope rather than a diversified national footprint. The disparity between its modest revenue and extremely low market cap often points to significant challenges in scaling profitability or market penetration, which are critical factors for investors assessing the viability of its long-term business model.

财务健康

The company reported revenue of $7.05M over the trailing twelve months, yet recorded a net income of -$17,796,000 and an EBITDA of -$10,504,000. The substantial gap between positive revenue and severe negative net income reveals a highly aggressive cost structure where operating expenses and cost of goods sold far exceed total sales, resulting in a loss of approximately 250% of revenue before taxes. Free cash flow stands at -$11,770,375, which indicates that the company is burning through its liquidity reserves to fund operations, thereby severely limiting its financial flexibility to weather market downturns or fund capital expenditures without external financing. The gross margin is listed at -44.5%, the operating margin at -253.1%, and the profit margin at -71.7%; these deeply negative figures collectively indicate that the company is unable to cover its direct production costs, let alone overhead expenses, with its current pricing model. On the balance sheet, the company holds $7.15M in cash against total debt of $1.48M, and the debt-to-equity ratio is 7.99, which suggests a leveraged position where debt obligations are significantly higher than equity, despite the high cash balance likely being used to service operations or cover losses. The current ratio is 2.42, which implies that the company currently holds sufficient current assets to cover its short-term liabilities more than twice over, indicating a technically healthy short-term liquidity position despite the operational losses. Return on equity is -116.6% and return on assets is -29.3%, metrics that reveal management has been ineffective at generating value from shareholder capital or utilizing the asset base to produce profits, instead eroding equity through consistent losses.

估值评估

The trailing twelve-month P/E ratio is not available due to negative earnings, while the forward P/E is recorded as -0.14; the divergence between these metrics, particularly the negative forward P/E, implies that the market is pricing in a continuation of significant earnings contraction rather than a turnaround trajectory. The price-to-book ratio stands at 0.07, indicating that the market values the company at less than 10% of its book value, which suggests a deep discount often associated with distressed assets or companies with negligible tangible asset backing. Price-to-sales is 0.22 and EV/EBITDA is 0.14, and these alternative valuation metrics suggest that investors are assigning extremely low value to the company's revenue generation and enterprise value relative to its earnings potential, reflecting high perceived risk. The 52-week high is $841.80 and the 52-week low is $1.95, meaning the current share price is trading at a level that is exceptionally close to the absolute bottom of its trading range, specifically just 0.23% above the 52-week low. The beta is 1.12, which indicates that the stock's price volatility is slightly higher than the broader market, suggesting that price swings in this asset will be amplified relative to the general market index during periods of turbulence.

Growth & Income

Revenue growth year-over-year is -43.1%, while earnings growth is not applicable due to the company's unprofitable status; this implies that the company is shrinking in terms of top-line sales, and without profitability, it cannot reinvest in growth to arrest the decline. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%; consequently, the company reinvests its limited earnings—or rather, relies on cash reserves—to sustain operations rather than distributing income to shareholders. This non-dividend profile combined with negative revenue growth and negative cash flow paints a picture of a firm that is currently unable to generate income for shareholders or fund expansion through organic growth. The overall growth and income profile is characterized by contraction in sales, a complete absence of dividend income, and a reliance on burning cash reserves to maintain a precarious operational stance.